ConductScience.org, home

Paper40451978

Familial adenomatous polyposis: non-surgical management of large bowel disease: endoscopic and chemoprevention strategies.

Daca-Álvarez M and 3 others. Fam Cancer, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Familial adenomatous polyposis: non-surgical management of large bowel disease: endoscopic and chemoprevention strategies. Papers, record 40451978. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40451978

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Familial adenomatous polyposis: non-surgical management of large bowel disease: endoscopic and chemoprevention strategies.
PubMed
Journal
Fam Cancer
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-06-01
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Daca-Álvarez MMaria
2Latchford AAndrew
3Pellisé MMaria
4Balaguer FFrancesc

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adenomatous Polyposis ColiMajor topic
ChemopreventionMajor topic
ColonoscopyMajor topic
Colorectal NeoplasmsMajor topic
Humans
Colectomy

References62

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125810493Colorectal cancer prevention and fishful thinking.J Natl Cancer Inst2015https://conductscience.org/library/papers/25810493PubMed
27049351A randomized trial of ascorbic acid in polyposis coli.Cancer1982https://conductscience.org/library/papers/7049351PubMed
323949425Risk of neoplastic change in ileal pouches in familial adenomatous polyposis.J Gastrointest Surg2013https://conductscience.org/library/papers/23949425PubMed
429423501Association of Sulindac and Erlotinib vs Placebo With Colorectal Neoplasia in Familial Adenomatous Polyposis: Secondary Analysis of a Randomized Clinical Trial.JAMA Oncol2018https://conductscience.org/library/papers/29423501PubMed
535570229Long-term chemoprevention in patients with adenomatous polyposis coli: an observational study.Fam Cancer2022https://conductscience.org/library/papers/35570229PubMed
635636921Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis.Gut2023https://conductscience.org/library/papers/35636921PubMed
723885143Phytoestrogens/insoluble fibers and colonic estrogen receptor β: randomized, double-blind, placebo-controlled study.World J Gastroenterol2013https://conductscience.org/library/papers/23885143PubMed
810874062The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.N Engl J Med2000https://conductscience.org/library/papers/10874062PubMed
912972960Risk of rectal cancer in patients after colectomy and ileorectal anastomosis for familial adenomatous polyposis: a function of available surgical options.Dis Colon Rectum2003https://conductscience.org/library/papers/12972960PubMed
107634976
Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment. Advantages of a low-dose nonsteroidal anti-inflammatory drug regimen in reversing adenomas exceeding 33 months.
Dis Colon Rectum1995https://conductscience.org/library/papers/7634976PubMed
111650315Sulindac causes regression of rectal polyps in familial adenomatous polyposis.Gastroenterology1991https://conductscience.org/library/papers/1650315PubMed
1224764585A phase Ib study of the effects of black raspberries on rectal polyps in patients with familial adenomatous polyposis.Cancer Prev Res (Phila)2014https://conductscience.org/library/papers/24764585PubMed
1321543343A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis.Cancer Prev Res (Phila)2011https://conductscience.org/library/papers/21543343PubMed
1434610992Celecoxib Colorectal Bioavailability and Chemopreventive Response in Patients with Familial Adenomatous Polyposis.Cancer Prev Res (Phila)2022https://conductscience.org/library/papers/34610992PubMed
158385741Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.N Engl J Med1993https://conductscience.org/library/papers/8385741PubMed
1633376109Sirolimus for the treatment of polyposis of the rectal remnant and ileal pouch in four patients with familial adenomatous polyposis: a pilot study.BMJ Open Gastroenterol2020https://conductscience.org/library/papers/33376109PubMed
1727002448Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial.JAMA2016https://conductscience.org/library/papers/27002448PubMed
1811932472Primary chemoprevention of familial adenomatous polyposis with sulindac.N Engl J Med2002https://conductscience.org/library/papers/11932472PubMed
198859177Effect of indomethacin suppositories on rectal polyposis in patients with familial adenomatous polyposis.Cancer1996https://conductscience.org/library/papers/8859177PubMed
2035812028Role of endoscopy in patients with familial adenomatous polyposis.Frontline Gastroenterol2022https://conductscience.org/library/papers/35812028PubMed

See all 62 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42315912MCM2 germline variants predispose to familial papillary thyroid carcinoma due to genomic instability caused by MCM complex disruption.Oncogene2026https://conductscience.org/library/papers/42315912PubMed
42239884Advances in chemoprevention of familial adenomatous polyposis.Front Oncol2026https://conductscience.org/library/papers/42239884PubMed
41228253Advances in Hereditary Colorectal Cancer: How Precision Medicine Is Changing the Game.Cancers (Basel)2025https://conductscience.org/library/papers/41228253PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
APC324PubTator's text mininghttps://conductscience.org/library/genes/324

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40451978

GET https://conductscience.org/api/papers/v1/40451978/references?page=2